Arnold F Jacobson
Overview
Explore the profile of Arnold F Jacobson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
1247
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pandit-Taskar N, Basu E, Balquin E, Mozley P, Jacobson A, Modak S
Nucl Med Commun
. 2024 Dec;
46(3):245-247.
PMID: 39641193
Objective: Limited safety data have been published on fluorine-18 ( 18 F) meta-fluorobenzylguanidine ( m FBG), a new PET radiopharmaceutical for imaging neural crest and neuroendocrine tumors. As part of...
2.
Verschure D, Poel E, Travin M, Henzlova M, Jain D, Jacobson A, et al.
Eur Heart J Cardiovasc Imaging
. 2021 Aug;
23(9):1201-1209.
PMID: 34427293
Aims: Cardiac 123iodine-meta-iodobenzylguanidine (123I-mIBG) single-photon emission computed tomography (SPECT) imaging provides information on regional myocardial innervation. However, the value of the commonly used 17-segment summed defect score (SDS) as a...
3.
Jacobson A, Narula J, Tijssen J
Am J Cardiol
. 2021 Aug;
156:85-92.
PMID: 34344513
Two widely used methods for left ventricular (LV) ejection fraction (EF) determination, echocardiography (echo) and gated single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI), often have wide limits of...
4.
5.
Jacobson A, Matsuoka D
J Gastroenterol Hepatol
. 2020 May;
35(12):2151-2157.
PMID: 32410288
Background And Aim: Imaging noradrenergic uptake in the liver with norepinephrine analog I-meta-iodobenzylguanidine (mIBG) was explored in normal controls and patients with heart failure (HF). Methods: A total of 961...
6.
Nakajima K, Nakata T, Doi T, Kadokami T, Matsuo S, Konno T, et al.
Eur Heart J Cardiovasc Imaging
. 2018 Feb;
19(7):749-756.
PMID: 29415138
Aims: The aim of this study was to validate a four-parameter risk model including 123I-meta-iodobenzylguanidine (MIBG) imaging, which was previously developed for predicting cardiac mortality, in a new cohort of...
7.
Cohen-Solal A, Jacobson A, Pina I
ESC Heart Fail
. 2017 Nov;
4(4):499-506.
PMID: 29154422
Aims: Extent of cardiac sympathetic activation can be estimated from physiological parameters, blood biomarkers, and imaging findings. This study examined the prognostic value of three markers of sympathetic activity and...
8.
Pina I, Carson P, Lindenfeld J, Archambault W, Jacobson A
Am J Cardiol
. 2016 Dec;
119(3):434-439.
PMID: 27912890
I-mIBG imaging has been evaluated to assess sympathetic function and prognosis in heart failure (HF). However, the effect of combined HF medical therapies on I-mIBG uptake and its prognostic significance...
9.
Nakajima K, Matsunari I, Jacobson A
J Nucl Cardiol
. 2016 Nov;
25(3):907-910.
PMID: 27896701
No abstract available.
10.
Jacobson A, White S, Travin M, Tseng C
Nucl Med Commun
. 2016 Nov;
38(2):141-148.
PMID: 27861299
Introduction: Medications that interfere with sympathetic neuronal norepinephrine uptake and storage, such as neuropsychiatrics (NP) and sympathomimetic amines, are most likely to affect cardiac uptake of iodine-123 metaiodobenzylguanidine (I-mIBG). The...